Copyright
©The Author(s) 2015.
World J Gastroenterol. Mar 14, 2015; 21(10): 3049-3054
Published online Mar 14, 2015. doi: 10.3748/wjg.v21.i10.3049
Published online Mar 14, 2015. doi: 10.3748/wjg.v21.i10.3049
Figure 1 Global and recurrence-free survivals (P = 0.
52).
Figure 2 Recurrence-free survival curves according to 18F-fluorodeoxyglucose-positron emission tomography intake with a cut-off at 1.
15 (P = 0.0004).
Figure 3 Receiver operating curve for recurrence.
ROC: Receiver operating curve.
Figure 4 Recurrence-free survival curves according to Milan criteria combined with 18F-fluorodeoxyglucose-positron emission tomography intake with a cut-off at 1.
15 (P = 0.0008).
Figure 5 Recurrence-free survival curves comparing Milan in (PET- and PET+) and Milan out with 18F-fluorodeoxyglucose-PET intake lower than 1.
15 (P = 0.78).
- Citation: Detry O, Govaerts L, Deroover A, Vandermeulen M, Meurisse N, Malenga S, Bletard N, Mbendi C, Lamproye A, Honoré P, Meunier P, Delwaide J, Hustinx R. Prognostic value of 18F-FDG PET/CT in liver transplantation for hepatocarcinoma. World J Gastroenterol 2015; 21(10): 3049-3054
- URL: https://www.wjgnet.com/1007-9327/full/v21/i10/3049.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i10.3049